Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10527
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid
- BROMOMETHOXYPHENYL INHIBITOR
- valine aspartyl ketone 29
- valine aspartyl ketone 6
- valine aspartyl ketone analog 10
|
BDBM106699
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine 1D receptor (5HT1D)
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Nitric-oxide synthase, brain
| - CHEMBL1957350
- US8586620, 46
|
BDBM10750
| 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Amine oxidase [flavin-containing] A
- Amine oxidase [flavin-containing] B
- Butyrylcholinesterase (BChE)
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase
| - (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl N-ethyl-N-methylcarbamate hydrochloride
- Aminoindan deriv. (R)18b
- Aminoindan deriv. (R)18b.HCl
- N-propargylaminoindan (R)18b.HCl
- R-CPAI
|
BDBM10853
| 1 | 5 | 7 | 0 | 0 | 0 | 0 | 0 | - Chitinase
- Chitinase (chiA1)
- Chitinase B
- Chitinase Mutant (A217G)
- Chitinase Mutant (D175A)
- Chitinase Mutant (E322A)
- Chitinase Mutant (M243A)
- Chitinase Mutant (R301K)
- Chitinase Mutant (T138A)
- Endochitinase B1
| - (2R,5S,8S,11S,15S)-8-benzyl-2,7-dimethyl-5-[3-({[(methylcarbamoyl)amino]methanimidoyl}amino)propyl]-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentaazacycloheptadecane-11,15-dicarboxylic acid
- Argifin
|
BDBM11337
| 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase
- Collagenase (ChC)
- Matrix Metalloproteinase-8 (MMP-8)
- Matrix metalloproteinase 12
- Matrix metalloproteinase-1 (MMP1)
- Stromelysin-1
| - 2-[benzyl(4-methoxybenzene)sulfonamido]-N-hydroxypropanamide
- CHEMBL316169
- Hydroxamate 18
|
BDBM11548
| 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - ADAM17
- Collagenase
- Matrix metalloproteinase-1 (MMP1)
| - CHEMBL100570
- N-hydroxy-2-[(4-methoxy-1,1-biphenyl-4-yl)methyl]isothiazolidine-3-carboxamide 1,1-dioxide
- N-hydroxy-2-{[4-(4-methoxyphenyl)phenyl]methyl}-1,1-dioxo-1,2-thiazolidine-3-carboxamide
- Sultam Hydroxamate 15a
|
BDBM12028
| 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - CDK2/CycE
- CDK2/Cyclin A/Cyclin A1
- CDK7/Cyclin H/MNAT1
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
- Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Cyclin-dependent kinase 4
- Cyclin-dependent kinase 9
| - 4-Arylazo-3,5-diamino-1H-pyrazole 31b
- 4-[(E)-2-(3,5-diamino-1H-pyrazol-4-yl)diazen-1-yl]phenol
- CAN508
|
BDBM12075
| 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Collagenase
- Matrix metalloproteinase-1 (MMP1)
- Matrix metalloproteinase-14 (MMP14)
- Matrix metalloproteinase-7 (MMP7)
- Stromelysin-1
| - (2S)-2-{[4-(4-bromophenyl)benzene]sulfonamido}-3-methylbutanoic acid
- CHEMBL43152
- alpha-arylsulfonylamino carboxylate 2S
|
BDBM123327
| 4 | 5 | 4 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 2
- Potassium voltage-gated channel subfamily H member 2
| |
BDBM12352
| 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Alkaline phosphatase, tissue-nonspecific isozyme
- Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(1-methyl-1H-imidazol-4-yl)pyridine
- CHEMBL360999
- US8609708, 5
- cid_11344157
- nicotine 3-heteroaromatic analogue 5
|
BDBM12356
| 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Alkaline phosphatase, tissue-nonspecific isozyme
- Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(2-methyl-1H-imidazol-1-yl)pyridine
- CHEMBL368883
- US8609708,13
- cid_16654686
- nicotine 3-heteroaromatic analogue 9
|
BDBM12358
| 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(4-methylthiophen-3-yl)pyridine
- CHEMBL179704
- US8609708, 17
- US8609708,17
- nicotine 3-heteroaromatic analogue 11
|
BDBM12577
| 3 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - Farnesyl Diphosphate Synthase (FPPS)
- Farnesyl diphosphate synthase
- Geranylgeranyl Diphosphate Synthase (GGPPS)
- Squalene synthetase
| - Bisphosphonate 2
- CHEMBL997
- JMC515594 Compound 53
- {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid
|
BDBM13054
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic Anhydrase VA
- Carbonic Anhydrase VB
- Carbonic Anhydrase XIII
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 4
- Carbonic anhydrase 6 (CA-VI)
- Carbonic anhydrase 7
- Carbonic anhydrase 9
| - (2R,4R)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1,7-thieno[2,3-b]thiopyran-6-sulfonamide
- Dorzolamide, DZA
- sulfonamide 5
|
BDBM13075
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic anhydrase 1
- Carbonic anhydrase 2
| - 2,4-dichloro-5-sulfamoylbenzoic acid
- 2000-01951
- Lasamide (Hsba)
- LeadQuest Compound 9
|
BDBM13280
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Trypsin II
- Trypsin-1
- Vitamin K-dependent protein C
| - 3-{[(3S)-3-[(7-methoxynaphthalene-2-)sulfonamido]-2-oxopyrrolidin-1-yl]methyl}benzene-1-carboximidamide
- CHEMBL327600
- Sulfonamidopyrrolidinone 3a
|
BDBM14047
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 2
- Glycogen synthase kinase-3
- Inhibitor of NF-kappa-B kinase (IKK)
- Mitogen-activated protein kinase 10
- RAC-alpha serine/threonine-protein kinase AKT1
- Rho-associated protein kinase 1
- Rho-associated protein kinase 2
- Ribosomal protein S6 kinase alpha 1
- Ribosomal protein S6 kinase alpha 5
- Serine/threonine-protein kinase AKT
- Serine/threonine-protein kinase AKT2
- Serine/threonine-protein kinase PLK1
| - Aminofurazanyl-azabenzimidazole 6n
- N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(morpholin-4-yl)ethoxy]benzamide
|
BDBM14150
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Trypsin-1
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| - APC-11417
- CA-12
- CRA-11417
- {amino[6-fluoro-2-(2-hydroxy-3-phenylphenyl)-1H-indol-5-yl]methylidene}azanium
|
BDBM14773
| 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Phosphodiesterase 4
- Phosphodiesterase 8
- Phosphodiesterase Type 10 (PDE10A)
- Phosphodiesterase Type 11 (PDE11A)
- Phosphodiesterase Type 2 (PDE2A)
- Phosphodiesterase Type 3 (PDE3B)
- Phosphodiesterase Type 4 (PDE4B)
- Phosphodiesterase Type 4 (PDE4D)
- Phosphodiesterase Type 5 (PDE5A)
- Phosphodiesterase Type 7 (PDE7B)
- Phosphodiesterase Type 9 (PDE9A)
| - 4-cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)cyclohexane-1-carboxylic acid
- 4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid
- Ariflo
- Cilomilast
- SB207499
|
BDBM148176
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Potassium voltage-gated channel subfamily H member 2
| - US8962616, 22
- US8962616, 4
|
BDBM15148
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - RAC-alpha serine/threonine-protein kinase AKT1
- Serine/threonine-protein kinase AKT
- Serine/threonine-protein kinase AKT2
- Serine/threonine-protein kinase Sgk1
| - 2,3-diphenylquinoxaline 1
- 2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine
|
BDBM15222
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic Anhydrase VA
- Carbonic Anhydrase VB
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| - 4-Azidobenzenesulfonamide
- 4-azidobenzene-1-sulfonamide
- CHEMBL222837
- azide 1
|
BDBM155255
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A
- Cytochrome P450 1A1
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 2D6 (2D6)
- H3K27me2
- H3K27me3
- Histone-lysine N-methyltransferase EZH2
| - US10098888, Compound 105
- US9006242, 105
|
BDBM160075
| 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C19
- P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
- P2X7 rat
- Potassium voltage-gated channel subfamily H member 2
| - US10047092, 16
- US9040534, 16
|
BDBM160130
| 5 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
- P2X7 rat
| - US10047092, 72
- US10053463, 72
- US9040534, 71
- US9040534, 72
|
BDBM162872
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- ATP-sensitive inward rectifier potassium channel 1
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Inward rectifier potassium channel 2
- Inward rectifier potassium channel 4
- Renal Outer Medullary Potassium (ROMK)
- Voltage-gated calcium channel
- Voltage-gated sodium channel subunit alpha Nav1.2 (Nav1.2)
| |
BDBM16294
| 10 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Enoyl-ACP Reductase (FabI)
- Enoyl-ACP Reductase (InhA)
- Enoyl-ACP reductase (FabI1)
- Enoyl-ACP reductase (Wt ypFabV)
- Enoyl-ACP reductase T276S (T276S ypFabV)
- Enoyl-[acyl-carrier-protein] reductase [NADH] (ftuFabl)
| - 2PP
- 5-Ethyl-2-phenoxy-phenol
- 5-butyl-2-phenoxylphenol
- 5-ethyl-2-phenoxyphenol
- AIDS227443
- PT01
- US10071965, Compound PT04
|
BDBM16316
| 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Inhibitor of NF-kappa-B kinase (IKK)
- MAP kinase p38
- MAP kinase-activated protein kinase 2
- Mitogen-activated protein kinase 14
- Protein kinase C alpha type
- Protein kinase C delta type
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
- Tyrosine-protein kinase SYK
- Tyrosine-protein kinase ZAP-70
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
- cAMP-dependent protein kinase (PKA)
| - 3-({4-[(2,2-dimethylpropyl)(methyl)amino]-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazin-2-yl}amino)-N-methoxy-4-methylbenzamide
- CHEMBL225088
- triaminotriazine aniline amide inhibitor, 1
|
BDBM170440
| 6 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2D6 (2D6)
- Monoamine transporters; serotonin & dopamine
- Sodium-dependent noradrenaline transporter
- Sodium-dependent serotonin transporter
| |
BDBM17060
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - MAP kinase p38
- Mitogen-activated protein kinase 10
- Mitogen-activated protein kinase 14
- Mitogen-activated protein kinase 3
- Non-receptor tyrosine-protein kinase TYK2
- Proto-oncogene tyrosine-protein kinase Src
- SRC
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
- Tyrosine-protein kinase Lyn
| - 1-(2,6-dichlorophenyl)-5-(2,4-difluorophenyl)-7-(piperidin-4-yl)-1,2,3,4-tetrahydroquinazolin-2-one
- CHEMBL319556
- Dihydro-quinazolinone analog, 9
|
BDBM17448
| 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Indoleamine 2,3-dioxygenase 1
- Methionine aminopeptidase 2
- Tryptophan 2,3-dioxygenase
| - 1,2,3-triazole analogue, 4
- 5-phenyl-1H-1,2,3-triazole
|
BDBM17744
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Fibroblast growth factor receptor 1
- Hepatocyte growth factor receptor
- Insulin-like growth factor I receptor
- Mitogen-activated protein kinase 10
- Mitogen-activated protein kinase 14
- Proto-oncogene tyrosine-protein kinase Src
- Tyrosine-protein kinase BTK
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
- Tyrosine-protein kinase ZAP-70
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| - 2,6-dimethylphenyl N-[2-({3,5-dimethoxy-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl}amino)pyrimidin-4-yl]-N-(2,4-dimethoxyphenyl)carbamate
- 2-aminopyrimidine carbamate, 43
|
BDBM18073
| 2 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Alkaline phosphatase, tissue-nonspecific isozyme
- Intestinal alkaline phosphatase
- Intestinal alkaline phosphatase (IAP)
- L-type amino acid transporter 1
- Phospholipase A-2-activating protein
- Tissue non-specific alkaline phosphatase (TNAP)
- Voltage-gated calcium channel alpha2/delta subunit 1
| - (2S)-2-amino-3-phenylpropanoic acid
- CHEMBL301523
- L-[2,3,4,5,6-3H]phenylalanine
- L-phenylalanine
- Phenylalanine
|
BDBM18361
| 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - β-galactosidase
- Acidic alpha-glucosidase
- Glucosylceramidase
- Lactase-glycosylceramidase
- Trehalase
- Uncharacterized protein
- alpha-Glucosidase (α-Glucosidase)
- alpha-Glucosidase (alpha-Glu)
| - (2R,3S,4R,5R,6R)-2-butyl-6-(hydroxymethyl)piperidine-3,4,5-triol
- alpha-1-C-Butyl-DNJ
|
BDBM18510
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydrofolate Reductase (DHFR)
- Dihydrofolate reductase
- Dihydrofolate reductase (DHFR)
| - 5-{3-[(2,4-diaminopyrimidin-5-yl)methyl]-4-methoxyphenoxy}pentanoic acid
- CHEMBL37520
- Diaminopyrimidine, 22
|
BDBM186927
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine receptor 1A (5HT1A)
- 5-hydroxytryptamine receptor 1D (5HT1D)
- 5-hydroxytryptamine receptor 2A (5HT2A)
- 5-hydroxytryptamine receptor 2B (5HT2B)
- 5-hydroxytryptamine receptor 2C (5HT2C)
- 5-hydroxytryptamine receptor 7 (5HT7)
- Alpha-1A adrenergic receptor
- Alpha-1B adrenergic receptor
- Alpha-1D adrenergic receptor
- Dopamine D1 receptor
- Dopamine D2 receptor
- Dopamine D3 receptor
- Dopamine D4 receptor
| |
BDBM18763
| 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydrofolate reductase
- Thymidylate Synthase (TS)
- Thymidylate synthase
- Thymidylate synthase (TS)
| - 1,8-naphthalein derivative, 10
- 4,4-bis(3-chloro-4-hydroxyphenyl)-3-oxatricyclo[7.3.1.0^{5,13}]trideca-1(12),5,7,9(13),10-pentaen-2-one
- A15
- A156
- Alpha 156
- CHEMBL67116
|
BDBM18778
| 10 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS)
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant KICB1
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant SP21
| - CHEMBL22405
- P16
- methyl 4-[2,6-diamino-5-(4-chlorophenyl)pyrimidin-4-yl]butanoate
|
BDBM18783
| 10 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS)
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant KICB1
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant SP21
| - 5-(3,4-dichlorophenyl)-6-ethylpyrimidine-2,4-diamine
- CHEMBL21799
- P13
|
BDBM18785
| 10 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS)
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant KICB1
- Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant SP21
| - 5-(3-chlorophenyl)-6-methylpyrimidine-2,4-diamine
- CHEMBL22039
- P38
|
BDBM18867
| 0 | 9 | 0 | 4 | 0 | 0 | 0 | 0 | - Thyroid Hormone Receptor (TR-beta)
- Thyroid hormone receptor
| - 2-{3,5-dibromo-4-[4-hydroxy-3-(propan-2-yl)phenoxy]phenyl}acetic acid
- KB-131092
- dibromo phenylacetic acid, 11a
|
BDBM19847
| 0 | 9 | 0 | 4 | 0 | 0 |